113 related articles for article (PubMed ID: 19834903)
1. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.
Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM
Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of tumor cells after induction of telomere dysfunction.
Zimmermann S; Biniossek ML; Pantic M; Pfeifer D; Veelken H; Martens UM
Proteomics; 2009 Feb; 9(3):521-34. PubMed ID: 19132685
[TBL] [Abstract][Full Text] [Related]
3. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
4. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
5. S100A6 binds p53 and affects its activity.
Słomnicki ŁP; Nawrot B; Leśniak W
Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
7. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
[TBL] [Abstract][Full Text] [Related]
8. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ
Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
11. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
Kang MK; Guo W; Park NH
Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392
[TBL] [Abstract][Full Text] [Related]
12. Telomerase, senescence and ageing.
Shawi M; Autexier C
Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
[TBL] [Abstract][Full Text] [Related]
13. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
14. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Pantic M; Zimmermann S; Waller CF; Martens UM
Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic profiling of tumor cell response to telomere dysfunction using isotope-coded protein labeling (ICPL) reveals interaction network of candidate senescence markers.
Biniossek ML; Lechel A; Rudolph KL; Martens UM; Zimmermann S
J Proteomics; 2013 Oct; 91():515-35. PubMed ID: 23969227
[TBL] [Abstract][Full Text] [Related]
17. Replicative senescence in sheep fibroblasts is a p53 dependent process.
Davis T; Skinner JW; Faragher RG; Jones CJ; Kipling D
Exp Gerontol; 2005; 40(1-2):17-26. PubMed ID: 15664728
[TBL] [Abstract][Full Text] [Related]
18. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Goodwin EC; DiMaio D
Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling.
Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J
Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350
[TBL] [Abstract][Full Text] [Related]
20. [Effects of 3'-azido-deoxythymidine on telomerase activity and protein expression of hepatocarcinoma cell line SMMC-7721].
He M; Jiang YY; Zhu M; Wei X; Qin J; Zhang ZY; Li L
Ai Zheng; 2006 May; 25(5):543-8. PubMed ID: 16687071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
